Nav: Home

Inflammatory mechanisms may underlie increased risk of prostate cancer among WTC responders

June 20, 2019

Bottom Line: Inflammatory and immune-regulatory mechanisms were found to be altered in animal models and in archived prostate cancer tumor samples of responders exposed to dust from the World Trade Center terrorist attacks on Sept. 11, 2001.

Journal in Which the Study was Published: Molecular Cancer Research, a journal of the American Association for Cancer Research

Authors: Emanuela Taioli, MD, PhD, director of the Institute for Translational Epidemiology at the Icahn School of Medicine at Mount Sinai and associate director for Population Science at the Tisch Cancer Institute, both in New York; and William Oh, MD, chief of the Division of Hematology and Medical Oncology at the Icahn School of Medicine at Mount Sinai and deputy director at the Tisch Cancer Institute

Background: "World Trade Center responders show an overall increase in cancer incidence, including prostate cancer," said Taioli. "It is important to address the reasons for this increased incidence in order to prevent new cases in this aging cohort."

Previous work has reported an increased incidence of prostate cancer among responders to attacks on the World Trade Center. However, because these responders have been closely monitored, it remains unknown whether this increased incidence is truly related to exposure to carcinogens in the World Trade Center dust or whether it is a result of surveillance bias, noted Taioli. "Our study aimed to determine potential underlying mechanisms that could explain the link between World Trade Center responders and increased prostate cancer incidence," she said.

How the Study Was Conducted and Results: To identify differential patterns of gene expression potentially caused by exposure to World Trade Center dust, the researchers compared archived prostate cancer tumors from unexposed individuals (14 patients) and World Trade Center responders (15 patients). Prostate cancer tumors taken from responders showed a downregulation of genes involved in immune-cell chemotaxis and proliferation and an upregulation of genes involved in apoptosis and immune modulation, compared with prostate cancer tumors taken from unexposed patients. Additionally, cell-type enrichment analyses revealed an upregulation of pro-inflammatory cell types in prostate cancer tissue samples taken from responders compared with samples taken from unexposed patients.

To understand how inhalation of World Trade Center dust may affect a healthy prostate, the researchers exposed rats to dust that was collected at Ground Zero within 72 hours after the attacks. Rats anesthetized using isoflurane received either a two-hour exposure to the dust or no exposure to the dust for two consecutive days. The dose was adjusted to mimic the level of dust first responders would have inhaled during the initial three days at Ground Zero. To identify both immediate and delayed responses to World Trade Center dust, rat prostates were harvested at one day or 30 days post exposure and analyzed.

Rat prostate samples taken after one day of exposure revealed an upregulation of pro-inflammatory cell types compared with controls. Prostate samples taken 30 days post exposure revealed an upregulation of genes involved in cholesterol biosynthesis compared with controls.

"Cholesterol is an important precursor to androgens, which are known to drive prostate cancer development," explained Oh. "Our preliminary finding that exposure to World Trade Center dust increased the expression of genes in the cholesterol biosynthesis pathway highlights an additional mechanism by which environmental exposures may lead to the progression of prostate cancer."

Author's Comments: "It has been recognized that inflammation may be an important consideration in prostate cancer progression," said Oh.

"In our study, both the archived human prostate cancer tissues of 9/11 responders and the prostates of rats experimentally exposed to World Trade Center dust showed an increase in pro-inflammatory cell types," noted Taioli. "This finding represents the first mechanistic link between exposure to World Trade Center dust and prostate cancer."

Oh noted, "Our results suggest that inflammatory mechanisms are activated in the prostate after exposure to World Trade Center dust, which may give rise to chronic inflammation and contribute to prostate cancer progression."

Study Limitations: Limitations of the study include a small sample size of archived human prostate samples.

Funding & Disclosures: This study was sponsored by grants from the Centers for Disease Control and Prevention and the National Institute for Occupational Safety and Health. Oh is a consultant/advisory board member for Sema4, CheckPoint Sciences, AstraZeneca, Sanofi, Genzyme, Bayer, and Janssen.
-end-


American Association for Cancer Research

Related Prostate Cancer Articles:

First prostate cancer therapy to target genes delays cancer progression
For the first time, prostate cancer has been treated based on the genetic makeup of the cancer, resulting in delayed disease progression, delayed time to pain progression, and potentially extending lives in patients with advanced, metastatic prostate cancer, reports a large phase 3 trial.
Men taking medications for enlarged prostate face delays in prostate cancer diagnosis
University of California San Diego School of Medicine researchers report that men treated with medications for benign prostatic hyperplasia (enlarged prostate) experienced a two-year delay in diagnosis of their prostate cancer and were twice as likely to have advanced disease upon diagnosis.
CNIO researchers confirm links between aggressive prostate cancer and hereditary breast cancer
The study has potential implications for families with members suffering from these types of tumours who are at an increased risk of developing cancer.
Distinguishing fatal prostate cancer from 'manageable' cancer now possible
Scientists at the University of York have found a way of distinguishing between fatal prostate cancer and manageable cancer, which could reduce unnecessary surgeries and radiotherapy.
Researchers find prostate cancer drug byproduct can fuel cancer cells
A genetic anomaly in certain men with prostate cancer may impact their response to common drugs used to treat the disease, according to new research at Cleveland Clinic.
More Prostate Cancer News and Prostate Cancer Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...